GSE119424 GSE120214 TBXT brachyury inhibition 1 v 4 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE119424_GSE120214_TBXT_brachyury inhibition_1_v_4_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE119424_GSE120214_TBXT_brachyury inhibition_1_v_4_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE119424_GSE120214_TBXT_brachyury inhibition_1_v_4_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE119424_GSE120214_TBXT_brachyury inhibition_1_v_4_human_up.

Results found

Linked to

 

Label

Description

 

Gene

C-X-C motif chemokine ligand 8

Gene

activating transcription factor 3

Gene

heme oxygenase 1

Gene

cystatin A

Gene

adhesion molecule with Ig like domain 2

Gene

amphiregulin

Gene

aldo-keto reductase family 1 member B10

Gene

metallothionein 1E

Gene

ChaC glutathione specific gamma-glutamylcyclotransferase 1

Gene

aldo-keto reductase family 1 member C1

  • Gene

    C-X-C motif chemokine ligand 8


  • Gene

    activating transcription factor 3


  • Gene

    heme oxygenase 1



  • Gene

    adhesion molecule with Ig like domain 2



  • Gene

    aldo-keto reductase family 1 member B10


  • Gene

    metallothionein 1E


  • Gene

    ChaC glutathione specific gamma-glutamylcyclotransferase 1


  • Gene

    aldo-keto reductase family 1 member C1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.